Center for Oncology

Publications

  1. 2011
  2. Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial.

    Schlemmer, M., Bauer, S., Schütte, R., Hartmann, J. T., Bokemeyer, C., Hosius, C. & Reichardt, P., 2011, In: EUR J MED RES. 16, 5, p. 206-212 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cells.

    Kern, W., Bacher, U., Haferlach, C., Schnittger, S. & Haferlach, T., 2011, In: LEUKEMIA LYMPHOMA. 52, 1, p. 92-100 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study.

    Schimmer, A. D., Herr, W., Hänel, M., Borthakur, G., Frankel, A., Horst, H-A., Martin, S., Kassis, J., Desjardins, P., Seiter, K., Fiedler, W., Noppeney, R., Giagounidis, A., Jacob, C., Jolivet, J., Tallman, M. S. & Koschmieder, S., 2011, In: CL LYMPH MYELOM LEUK. 11, 5, p. 433-438 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Adjuvant Therapy After Liver Resection for Colorectal Cancer Metastasis: What is the Evidence?

    Arnold, D. & Stein, A., 2011, In: CURR COLORECT CANC R. 7, 2, p. 180-186 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Adjuvant Therapy for Early Colon Cancer: Current Status.

    Stein, A., Hiemer, S. & Schmoll, H-J., 2011, In: DRUGS. 71, 17, p. 2257-2275 17.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Akute Blutungen ohne Trauma - Gerinnung checken mit System

    Langer, F., Holstein, K. & Bokemeyer, C., 2011, In: Der Allgemeinarzt. 33, 15, p. 37-40 15.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.

    Kröger, N., Zabelina, T., van Biezen, A., Brand, R., Niederwieser, D., Martino, R., Lim, Z. Y., Onida, F., Schmid, C., Garderet, L., Robin, M., van Gelder, M., Marks, R., Symeonidis, A., Kobbe, G. & de Witte, T., 2011, In: HAEMATOLOGICA. 96, 2, p. 291-297 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Antiinflammatorisch wirksame Phytotherapeutika und ihr mögliches Potential bei tumorkranken Menschen

    Saller, R., Melzer, J. & Rostock, M., 2011, In: FORSCH KOMPLEMENTMED. 18, 4, p. 203-12 10 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  10. A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC).

    Grünwald, V., Desar, I. M. E., Haanen, J., Fiedler, W., Mouritzen, U., Olsen, M. W. B., Herpen, V. & Carla, M. L., 2011, In: ACTA ONCOL. 50, 1, p. 121-126 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Approaches to relapse after allogeneic stem cell transplantation.

    Kröger, N., 2011, In: CURR OPIN ONCOL. 23, 2, p. 203-208 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974).

    Daugaard, G., Skoneczna, I., Aass, N., De Wit, R., De Santis, M., Dumez, H., Marreaud, S., Collette, L., Lluch, J. R. G., Bokemeyer, C. & Schmoll, H. J., 2011, In: ANN ONCOL. 22, p. 1054-1061

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Assessment of physiologic natural killer cell cytotoxicity in vitro.

    Duske, H., Sputtek, A., Binder, T., Kröger, N., Schrepfer, S. & Eiermann, T., 2011, In: HUM IMMUNOL. 72, 11, p. 1007-1012 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. ATR-p53 restricts homologous recombination in response to replicative stress but does not limit DNA interstrand crosslink repair in lung cancer cells.

    Sirbu, B. M., Lachmayer, S. J., Wülfing, V., Marten, L. M., Clarkson, K. E., Lee, L. W., Gheorghiu, L., Zou, L., Powell, S. N., Dahm-Daphi, J. & Willers, H., 2011, In: PLOS ONE. 6, 8, p. 23053 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia.

    Binder, M., Müller, F., Jackst, A., Lechenne, B., Pantic, M., Bacher, U., Zu Eulenburg, C. G., Veelken, H., Mertelsmann, R., Pasqualini, R., Arap, W. & Trepel, M., 2011, In: CANCER-AM CANCER SOC. 117, 9, p. 1891-1900 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.

    Duy, C., Hurtz, C., Shojaee, S., Cerchietti, L., Geng, H., Swaminathan, S., Klemm, L., Kweon, S., Nahar, R., Balabanov, M., Park, E., Kim, Y., Hofmann, W-K., Herzog, S., Jumaa, H., Koeffler, H. P., Yu, J. J., Heisterkamp, N., Graeber, T. G., Wu, H., Ye, B. H., Melnick, A. & Müschen, M., 2011, In: NATURE. 473, 7347, p. 384-388 7347.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia.

    Hurtz, C., Hatzi, K., Cerchietti, L., Balabanov, M., Park, E., Kim, Y., Herzog, S., Ramezani-Rad, P., Jumaa, H., Müller, M. C., Hofmann, W-K., Hochhaus, A., Ye, B. H., Agarwal, A., Druker, B. J., Shah, N. P., Melnick, A. M. & Müschen, M., 2011, In: J EXP MED. 208, 11, p. 2163-2174 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Bioequivalence comparison of a new freezing bag (CryoMACS(®)) with the Cryocyte(®) freezing bag for cryogenic storage of human hematopoietic progenitor cells.

    Sputtek, A., Lioznov, M., Kröger, N. & Rowe, A. W., 2011, In: CYTOTHERAPY. 13, 4, p. 481-489 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer.

    Grimminger, P. P., Danenberg, P., Dellas, K., Arnold, D., Rödel, C., Machiels, J-P., Haustermans, K., Debucquoy, A., Velenik, V., Sempoux, C., Bracko, M., Hölscher, A. H., Semrau, R., Yang, D., Danenberg, K., Lenz, H-J. & Vallböhmer, D., 2011, In: CLIN CANCER RES. 17, 10, p. 3469-3477 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats.

    Meyer-Schwesinger, C., Lange, C., Bröcker, V., Agustian, P. A., Putri, A. A., Lehmann, U., Raabe, A., Brinkmeyer, M., Kobayashi, E., Schiffer, M., Büsche, G., Kreipe, H. H., Thaiss, F. & Becker, J. U., 2011, In: AM J PATHOL. 178, 2, p. 494-499 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Brachyury expression predicts poor prognosis at early stages of colorectal cancer.

    Kilic, N., Feldhaus, S., Kilic, E., Tennstedt, P., Wicklein, D., Wasielewski, R. V., Viebahn, C., Kreipe, H. & Schumacher, U., 2011, In: EUR J CANCER. 47, 7, p. 1080-1085 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors.

    Spyra, M., Kluwe, L., Hagel, C., Nguyen, R., Panse, J., Kurtz, A., Mautner, V. F., Rabkin, S. D. & Demestre, M., 2011, In: PLOS ONE. 6, 6, p. 21099 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect.

    Preuß, E., Muik, A., Riecken, K., Otte, J., von Laer, D. & Fehse, B., 2011, In: J MOL MED. 89, 11, p. 1113-1124 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.

    Atanackovic, D., Luetkens, T., Kloth, B., Fuchs, G., Cao, Y., Hildebrandt, Y., Meyer, S., Bartels, K., Reinhard, H., Lajmi, N., Hegewisch-Becker, S., Schilling, G., Platzbecker, U., Kobbe, G., Schroeder, T., Bokemeyer, C. & Kröger, N., 2011, In: AM J HEMATOL. 86, 11, p. 918-922 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.

    Lellek, H., Waldenmaier, D., Dahlke, J., Ayuketang Ayuk, F., Wolschke, C., Kröger, N. & Zander, A. R., 2011, In: MYCOSES. 54, 1, p. 39-44 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.

    Haferlach, C., Bacher, U., Kohlmann, A., Schindela, S., Alpermann, T., Kern, W., Schnittger, S. & Haferlach, T., 2011, In: HAEMATOLOGICA. 96, 6, p. 829-836 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplification.

    Kasten-Pisula, U., Saker, J., Eicheler, W., Krause, M., Yaromina, A., Meyer-Staeckling, S., Scherkl, B., Kriegs, M., Brandt, B., Grénman, R., Petersen, C., Baumann, M. & Dikomey, E., 2011, In: INT J RADIAT ONCOL. 80, 4, p. 1181-1188 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Challenges for allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

    Oyekunle, A., Klyuchnikov, E., Ocheni, S., Kröger, N., Zander, A. R., Baccarani, M. & Bacher, U., 2011, In: ACTA HAEMATOL-BASEL. 126, 1, p. 30-39 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms.

    Schnittger, S., Bacher, U., Haferlach, C., Alpermann, T., Dicker, F., Sundermann, J., Kern, W. & Haferlach, T., 2011, In: LEUKEMIA. 25, 4, p. 615-621 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Chondrogenic differentiation of human mesenchymal stem cells in micro-masses is impaired by high doses of the chemokine CXCL7.

    Kalwitz, G., Neumann, K., Ringe, J., Sezer, O., Sittinger, M., Endres, M. & Kaps, C., 2011, In: J TISSUE ENG REGEN M. 5, 1, p. 50-59 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT.

    Alchalby, H., Lioznov, M., Fritzsche-Friedland, U., Badbaran, A., Zabelina, T., Bacher, U., Stübig, T., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2011, In: BONE MARROW TRANSPL. 47, 1, p. 143-145 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Clinical experience with antiangiogenic therapy in leukemia.

    Wellbrock, J. & Fiedler, W., 2011, In: CURR CANCER DRUG TAR. 11, 9, p. 1053-1068 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.

    Schnittger, S., Bacher, U., Haferlach, C., Kern, W., Alpermann, T. & Haferlach, T., 2011, In: HAEMATOLOGICA. 96, 12, p. 1799-1807 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase.

    Schultze, A. & Fiedler, W., 2011, In: ANTI-CANCER AGENT ME. 11, 7, p. 593-599 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Clinical management of primary vulvar cancer.

    Wölber, L., Kock, L., Gieseking, F., Petersen, C., Trillsch, F., Choschzick, M., Jänicke, F. & Mahner, S., 2011, In: EUR J CANCER. 47, 15, p. 2315-2321 15.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Coffee consumption modifies risk of estrogen-receptor negative breast cancer.

    Li, J., Seibold, P., Chang-Claude, J., Flesch-Janys, D., Liu, J., Czene, K., Humphreys, K. & Hall, P., 2011, In: BREAST CANCER RES. 13, 3, p. 49 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck.

    Rades, D., Kronemann, S., Meyners, T., Bohlen, G., Tribius, S., Kazic, N., Schroeder, U., Hakim, S. G., Schild, S. E. & Dunst, J., 2011, In: INT J RADIAT ONCOL. 80, 4, p. 1037-1044 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.

    Bacher, U., Haferlach, C., Alpermann, T., Kern, W., Schnittger, S. & Haferlach, T., 2011, In: HAEMATOLOGICA. 96, 9, p. 1284-1292 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.

    Rades, D., Meyners, T., Kazic, N., Bajrovic, A., Rudat, V. & Schild, S. E., 2011, In: STRAHLENTHER ONKOL. 187, 9, p. 541-547 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. [Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy].

    Müller, F., Riesenberg, H., Hirnle, P., Gehl, H-B., Düwel, P. & Görner, M., 2011, In: STRAHLENTHER ONKOL. 187, 12, p. 826-830 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.

    Milne, R. L., Goode, E. L., García-Closas, M., Couch, F. J., Severi, G., Hein, R., Fredericksen, Z., Malats, N., Zamora, M. P., Pérez, A., Ignacio, J., Benítez, J., Dörk, T., Schürmann, P., Karstens, J. H., Hillemanns, P., Cox, A., Brock, I. W., Elliot, G., Cross, S. S., Seal, S., Turnbull, C., Renwick, A., Rahman, N., Shen, C-Y., Yu, J-C., Huang, C-S., Hou, M-F., Nordestgaard, B. G., Bojesen, S. E., Lanng, C., Grethe, G. A., Kristensen, V., Børrensen-Dale, A-L., Hopper, J. L., Dite, G. S., Apicella, C., Southey, M. C., Lambrechts, D., Yesilyurt, B. T., Floris, G., Leunen, K., Sangrajrang, S., Gaborieau, V., Brennan, P., McKay, J., Chang-Claude, J., Wang-Gohrke, S., Radice, P., Peterlongo, P., Manoukian, S., Barile, M., Giles, G. G., Baglietto, L., John, E. M., Miron, A., Chanock, S. J., Lissowska, J., Sherman, M. E., Figueroa, J. D., Bogdanova, N. V., Antonenkova, N. N., Zalutsky, I. V., Rogov, Y. I., Fasching, P. A., Bayer, C. M., Ekici, A. B., Beckmann, M. W., Brenner, H., Müller, H., Arndt, V., Stegmaier, C., Andrulis, I. L., Knight, J. A., Glendon, G., Mulligan, A. M., Mannermaa, A., Kataja, V., Kosma, V-M., Hartikainen, J. M., Meindl, A., Heil, J., Bartram, C. R., Schmutzler, R. K., Thomas, G. D., Hoover, R. N., Fletcher, O., Gibson, L. J., Isabel, D. S. S., Peto, J., Flesch-Janys, D., Flesch-Janys, D., Anton-Culver, H., Ziogas, A., Sawyer, E., Tomlinson, I., Kerin, M., Miller, N., Schmidt, M. K., Broeks, A., Tollenaar, R. A. E. M., Pharoah, P. D. P., Dunning, A. M., Pooley, K. A., Marme, F., Schneeweiss, A., Sohn, C., Burwinkel, B., Jakubowska, A., Lubinski, J., Jaworska, K., Durda, K., Kang, D., Yoo, K-Y., Noh, D-Y., Ahn, S-H., Hunter, D. J., Hankinson, S. E., Kraft, P., Lindstrom, S., Chen, X., Beesley, J., Hamann, U., Harth, V., Justenhoven, C., Network, GENICA., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Grip, M., Hooning, M., Hollestelle, A., Oldenburg, R. A., Tilanus-Linthorst, M., Khusnutdinova, E., Bermisheva, M., Prokofieva, D., Farahtdinova, A., Olson, J. E., Wang, X., Humphreys, M. K., Wang, Q., Chenevix-Trench, G., Group, AOCS. & Easton, D. F., 2011, In: CANCER EPIDEM BIOMAR. 20, 10, p. 2222-2231 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

    Wolff, D., Schleuning, M., von Harsdorf, S., Bacher, U., Gerbitz, A., Stadler, M., Ayuketang Ayuk, F., Kiani, A., Schwerdtfeger, R., Vogelsang, G. B., Kobbe, G., Gramatzki, M., Lawitschka, A., Mohty, M., Pavletic, S. Z., Greinix, H. & Holler, E., 2011, In: BIOL BLOOD MARROW TR. 17, 1, p. 1-17 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.

    Munshi, N. C., Anderson, K. C., Bergsagel, P. L., Shaughnessy, J., Palumbo, A., Durie, B., Fonseca, R., Stewart, A. K., Harousseau, J-L., Dimopoulos, M., Jagannath, S., Hajek, R., Sezer, O., Kyle, R., Sonneveld, P., Cavo, M., Rajkumar, S. V., Jesus, S. M., Crowley, J. & Avet-Loiseau, H., 2011, In: BLOOD. 117, 18, p. 4696-4700 18.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

    Rajkumar, S. V., Harousseau, J-L., Durie, B., Anderson, K. C., Dimopoulos, M., Kyle, R., Blade, J., Richardson, P., Orlowski, R., Siegel, D., Jagannath, S., Facon, T., Avet-Loiseau, H., Lonial, S., Palumbo, A., Zonder, J., Ludwig, H., Vesole, D., Sezer, O., Munshi, N. C. & Jesus, S. M., 2011, In: BLOOD. 117, 18, p. 4691-4695 18.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Contrast-Enhanced [(18)F]fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Staging and Radiotherapy Planning in Patients with Anal Cancer.

    Bannas, P., Weber, C., Adam, G., Frenzel, T., Derlin, T., Mester, J. & Klutmann, S., 2011, In: INT J RADIAT ONCOL. 81, 2, p. 445-451 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Control of bone formation by the serpentine receptor Frizzled-9.

    Albers, J., Schulze, J., Beil, F. T., Gebauer, M., Baranowsky, A., Keller, J., Marshall, R-P., Wintges, K., Friedrich, F., Priemel, M., Schilling, A., Rueger, J. M., Cornils, K., Fehse, B., Streichert, T., Sauter, G., Jakob, F., Insogna, K. L., Pober, B., Knobeloch, K-P., Francke, U., Amling, M. & Schinke, T., 2011, In: J CELL BIOL. 192, 6, p. 1057-1072 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Current standards and new trends in the primary treatment of colorectal cancer.

    Stein, A., Atanackovic, D. & Bokemeyer, C., 2011, In: EUR J CANCER. 47 Suppl 3, p. 312-314

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Cytogenetic methods in chronic lymphocytic leukemia.

    Haferlach, C. & Bacher, U., 2011, In: Methods Mol Biol. 730, p. 119-130

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.

    Friend, E., Yadegarfar, G., Byrne, C., Johnson, C. D., Sezer, O., Pucciarelli, S., Pereira, S. P., Chie, W-C., Banfield, A., Ramage, J. K. & Group, EORTC. Q. O. L., 2011, In: BRIT J CANCER. 104, 4, p. 587-592 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Dietary patterns and the risk of postmenopausal breast cancer in a German case-control study.

    Buck, K., Vrieling, A., Flesch-Janys, D. & Chang-Claude, J., 2011, In: CANCER CAUSE CONTROL. 22, 2, p. 273-282 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. Do centrally pre-prepared solutions achieve more reliable drug concentrations than solutions prepared on the ward?

    Dehmel, C., Braune, S., Kreymann, K-G., Baehr, M., Langebrake, C., Hilgarth, H., Nierhaus, A., Dartsch, D. C. & Kluge, S., 2011, In: INTENS CARE MED. 37, 8, p. 1311-1316 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review